Posted on March 10th, 2009 by Health News
The preliminary results of the most extensive randomised trial of ovarian cancer screening so far, are published Online First and in the April edition of The Lancet Oncology. The findings indicate that detecting early stage ovarian cancer is possible with the CA125 blood test and transvaginal ultrasound, with almost half of the cancers in stage [...]
No Comments »
Filed under: Women's Health
Posted on March 10th, 2009 by Health News
Azaya Therapeutics, Inc. has announced that it has been selected by the National Cancer Institute (NCI) for a research collaboration to study Azaya’s lead cancer therapy, ATI - 1123.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
CytoDyn, Inc. has sent the FDA what the Company believes is a complete response to the agency’s preliminary comments on Cytolin, a monoclonal antibody designed to restore immune function in those afflicted with HIV/AIDS.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
With obesity reaching epidemic levels, researchers at the Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Molecular dermatology research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers of genetic tests for predicting the risk of male and female hair loss, today introduced The HairDX (RxR) Genetic Test for Finasteride - a breakthrough genetic test for predicting Finasteride response for the treatment of common hair loss (Androgenetic Alopecia).
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that the Company has completed several key initiatives in preparation for the upcoming clinical trial in Germany using the Company’s placental-derived stem cell product candidate, PLX-PAD.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Azaya Therapeutics, Inc. has announced that it has been selected by the National Cancer Institute (NCI) for a research collaboration to study Azaya’s lead cancer therapy, ATI - 1123.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Ecstasy may help suffers of post-traumatic stress learn to deal with their memories more effectively by encouraging a feeling of safety, according to an article in the Journal of Psychopharmacology published by SAGE.
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Molecular dermatology research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), pioneers of genetic tests for predicting the risk of male and female hair loss, today introduced The HairDX (RxR) Genetic Test for Finasteride - a breakthrough genetic test for predicting Finasteride response for the treatment of common hair loss (Androgenetic Alopecia).
No Comments »
Filed under: Pharmacy News
Posted on March 10th, 2009 by Health News
Men with higher vitamin C intake appear less likely to develop gout, a painful type of arthritis, according to a report in the March 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
No Comments »
Filed under: Pharmacy News
